Rank | Gene Set | Z-score |
---|---|---|
1 | central nervous system myelination (GO:0022010) | 4.99626110 |
2 | axon ensheathment in central nervous system (GO:0032291) | 4.99626110 |
3 | L-phenylalanine catabolic process (GO:0006559) | 4.42803428 |
4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.42803428 |
5 | regulation of activation of Janus kinase activity (GO:0010533) | 4.17328593 |
6 | fatty acid elongation (GO:0030497) | 4.16836939 |
7 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.97958042 |
8 | L-phenylalanine metabolic process (GO:0006558) | 3.97958042 |
9 | neutrophil activation involved in immune response (GO:0002283) | 3.88527685 |
10 | negative regulation of cholesterol transport (GO:0032375) | 3.66020548 |
11 | negative regulation of sterol transport (GO:0032372) | 3.66020548 |
12 | aromatic amino acid family catabolic process (GO:0009074) | 3.61037549 |
13 | creatine metabolic process (GO:0006600) | 3.49536038 |
14 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.48235761 |
15 | plasma lipoprotein particle assembly (GO:0034377) | 3.44796258 |
16 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 3.43143572 |
17 | T-helper 1 type immune response (GO:0042088) | 3.40295895 |
18 | plasma lipoprotein particle clearance (GO:0034381) | 3.36167563 |
19 | protein-lipid complex assembly (GO:0065005) | 3.33518432 |
20 | heme transport (GO:0015886) | 3.25696703 |
21 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.16696072 |
22 | detection of other organism (GO:0098543) | 3.12135086 |
23 | regulation of cytokine secretion involved in immune response (GO:0002739) | 3.10929669 |
24 | detection of bacterium (GO:0016045) | 3.09278687 |
25 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 3.04896391 |
26 | tryptophan metabolic process (GO:0006568) | 3.04762916 |
27 | cholesterol biosynthetic process (GO:0006695) | 3.02249628 |
28 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.00316717 |
29 | aromatic amino acid family metabolic process (GO:0009072) | 2.99441753 |
30 | tyrosine metabolic process (GO:0006570) | 2.97434524 |
31 | high-density lipoprotein particle remodeling (GO:0034375) | 2.96399640 |
32 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.95284851 |
33 | adhesion of symbiont to host cell (GO:0044650) | 2.94090627 |
34 | virion attachment to host cell (GO:0019062) | 2.94090627 |
35 | indole-containing compound catabolic process (GO:0042436) | 2.90674642 |
36 | indolalkylamine catabolic process (GO:0046218) | 2.90674642 |
37 | tryptophan catabolic process (GO:0006569) | 2.90674642 |
38 | positive regulation of interleukin-17 production (GO:0032740) | 2.88323729 |
39 | low-density lipoprotein particle clearance (GO:0034383) | 2.87022679 |
40 | bile acid biosynthetic process (GO:0006699) | 2.84990696 |
41 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.84155345 |
42 | reverse cholesterol transport (GO:0043691) | 2.81535683 |
43 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.79533024 |
44 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.79018350 |
45 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.78450348 |
46 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.77845757 |
47 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.77845757 |
48 | regulation of triglyceride catabolic process (GO:0010896) | 2.77631138 |
49 | epoxygenase P450 pathway (GO:0019373) | 2.77374645 |
50 | axon ensheathment (GO:0008366) | 2.76371413 |
51 | ensheathment of neurons (GO:0007272) | 2.76371413 |
52 | striated muscle atrophy (GO:0014891) | 2.75898457 |
53 | alkaloid metabolic process (GO:0009820) | 2.75577297 |
54 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.75113256 |
55 | kynurenine metabolic process (GO:0070189) | 2.74172256 |
56 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.72046880 |
57 | protein carboxylation (GO:0018214) | 2.72018818 |
58 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.72018818 |
59 | macrophage activation involved in immune response (GO:0002281) | 2.70617624 |
60 | myelination (GO:0042552) | 2.70073555 |
61 | skeletal muscle adaptation (GO:0043501) | 2.69839732 |
62 | plasma lipoprotein particle remodeling (GO:0034369) | 2.69665809 |
63 | protein-lipid complex remodeling (GO:0034368) | 2.69665809 |
64 | macromolecular complex remodeling (GO:0034367) | 2.69665809 |
65 | cysteine metabolic process (GO:0006534) | 2.68121218 |
66 | complement activation, alternative pathway (GO:0006957) | 2.67704009 |
67 | sterol biosynthetic process (GO:0016126) | 2.67495770 |
68 | negative regulation of macroautophagy (GO:0016242) | 2.66449381 |
69 | glyoxylate metabolic process (GO:0046487) | 2.64835036 |
70 | serine family amino acid catabolic process (GO:0009071) | 2.64011423 |
71 | detection of external biotic stimulus (GO:0098581) | 2.63698367 |
72 | negative regulation of lipid storage (GO:0010888) | 2.62817104 |
73 | positive regulation of antigen processing and presentation (GO:0002579) | 2.62715873 |
74 | negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804) | 2.61975303 |
75 | peptide catabolic process (GO:0043171) | 2.60555030 |
76 | plasma lipoprotein particle organization (GO:0071827) | 2.60155606 |
77 | regulation of cholesterol esterification (GO:0010872) | 2.59744594 |
78 | cholesterol efflux (GO:0033344) | 2.59590536 |
79 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 2.59570948 |
80 | regulation of cholesterol homeostasis (GO:2000188) | 2.59415192 |
81 | protein-lipid complex subunit organization (GO:0071825) | 2.59133801 |
82 | phospholipid homeostasis (GO:0055091) | 2.59096554 |
83 | urea metabolic process (GO:0019627) | 2.58883601 |
84 | urea cycle (GO:0000050) | 2.58883601 |
85 | flavonoid metabolic process (GO:0009812) | 2.58866826 |
86 | complement activation, classical pathway (GO:0006958) | 2.58411583 |
87 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.58360975 |
88 | regulation of protein activation cascade (GO:2000257) | 2.57558107 |
89 | regulation of superoxide anion generation (GO:0032928) | 2.57461463 |
90 | amine catabolic process (GO:0009310) | 2.56497986 |
91 | cellular biogenic amine catabolic process (GO:0042402) | 2.56497986 |
92 | alpha-linolenic acid metabolic process (GO:0036109) | 2.56487605 |
93 | low-density lipoprotein particle remodeling (GO:0034374) | 2.53765089 |
94 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 2.53596367 |
95 | cofactor catabolic process (GO:0051187) | 2.52559076 |
96 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.52345936 |
97 | cholesterol homeostasis (GO:0042632) | 2.51802716 |
98 | sulfur amino acid catabolic process (GO:0000098) | 2.51158125 |
99 | vitamin transmembrane transport (GO:0035461) | 2.49381167 |
100 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.49174750 |
101 | neurotransmitter catabolic process (GO:0042135) | 2.49027617 |
102 | long-chain fatty acid biosynthetic process (GO:0042759) | 2.48549847 |
103 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.47821671 |
104 | carnitine shuttle (GO:0006853) | 2.47751773 |
105 | positive regulation of cellular amine metabolic process (GO:0033240) | 2.47122977 |
106 | bile acid metabolic process (GO:0008206) | 2.46895273 |
107 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.46679299 |
108 | sterol homeostasis (GO:0055092) | 2.46596283 |
109 | regulation of complement activation (GO:0030449) | 2.45915194 |
110 | lipoprotein metabolic process (GO:0042157) | 2.45854463 |
111 | labyrinthine layer development (GO:0060711) | 2.44156029 |
112 | intestinal epithelial cell development (GO:0060576) | 2.43424149 |
113 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.42834970 |
114 | angiotensin maturation (GO:0002003) | 2.42622218 |
115 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 2.42527418 |
116 | positive regulation by symbiont of host defense response (GO:0052509) | 2.42081725 |
117 | modulation by symbiont of host defense response (GO:0052031) | 2.42081725 |
118 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.42081725 |
119 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.42081725 |
120 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.42081725 |
121 | modulation by symbiont of host immune response (GO:0052553) | 2.42081725 |
122 | granulocyte activation (GO:0036230) | 2.41800127 |
123 | very long-chain fatty acid metabolic process (GO:0000038) | 2.41404226 |
124 | amyloid precursor protein metabolic process (GO:0042982) | 2.40823201 |
125 | immunoglobulin mediated immune response (GO:0016064) | 2.40630612 |
126 | pyridine-containing compound biosynthetic process (GO:0072525) | 2.40551542 |
127 | regulation of antigen processing and presentation (GO:0002577) | 2.40519630 |
128 | negative regulation of protein localization to cell surface (GO:2000009) | 2.39973332 |
129 | cellular glucuronidation (GO:0052695) | 2.39607842 |
130 | phospholipid efflux (GO:0033700) | 2.39064007 |
131 | complement activation (GO:0006956) | 2.38902854 |
132 | muscle atrophy (GO:0014889) | 2.38647799 |
133 | nitrogen cycle metabolic process (GO:0071941) | 2.38437392 |
134 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.38432838 |
135 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.38378934 |
136 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.37582930 |
137 | cell proliferation involved in metanephros development (GO:0072203) | 2.36846716 |
138 | establishment of skin barrier (GO:0061436) | 2.35483209 |
139 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.35052685 |
140 | positive regulation of humoral immune response (GO:0002922) | 2.34886930 |
141 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.34792357 |
142 | homocysteine metabolic process (GO:0050667) | 2.34788753 |
143 | aldehyde catabolic process (GO:0046185) | 2.34724965 |
144 | natural killer cell mediated immunity (GO:0002228) | 2.33602244 |
145 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.33602244 |
146 | detection of molecule of bacterial origin (GO:0032490) | 2.33545498 |
147 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.33514661 |
148 | positive thymic T cell selection (GO:0045059) | 2.33061713 |
149 | acetyl-CoA metabolic process (GO:0006084) | 2.32476322 |
150 | regulation of water loss via skin (GO:0033561) | 2.32289403 |
151 | glutathione derivative biosynthetic process (GO:1901687) | 2.31868120 |
152 | glutathione derivative metabolic process (GO:1901685) | 2.31868120 |
153 | amino-acid betaine metabolic process (GO:0006577) | 2.31849375 |
154 | positive regulation of lipid catabolic process (GO:0050996) | 2.31781198 |
155 | lung lobe morphogenesis (GO:0060463) | 2.31720792 |
156 | regulation of macrophage chemotaxis (GO:0010758) | 2.31332690 |
157 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.29972110 |
158 | regulation of sterol transport (GO:0032371) | 2.27709003 |
159 | regulation of cholesterol transport (GO:0032374) | 2.27709003 |
160 | response to thyroid hormone (GO:0097066) | 2.27610662 |
161 | detection of biotic stimulus (GO:0009595) | 2.27062262 |
162 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.26423472 |
163 | uronic acid metabolic process (GO:0006063) | 2.25246772 |
164 | glucuronate metabolic process (GO:0019585) | 2.25246772 |
165 | germinal center formation (GO:0002467) | 2.24754417 |
166 | cellular response to ethanol (GO:0071361) | 2.24606834 |
167 | negative regulation of lipid transport (GO:0032369) | 2.23335815 |
168 | regulation of apoptotic cell clearance (GO:2000425) | 2.23148885 |
169 | protein activation cascade (GO:0072376) | 2.22146467 |
170 | transcytosis (GO:0045056) | 2.20971233 |
171 | negative regulation of protein activation cascade (GO:2000258) | 2.20908434 |
172 | keratan sulfate catabolic process (GO:0042340) | 2.20707037 |
173 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.19387003 |
174 | regulation of humoral immune response (GO:0002920) | 2.19224845 |
175 | lipoprotein transport (GO:0042953) | 2.18722659 |
176 | fat-soluble vitamin biosynthetic process (GO:0042362) | 2.18109006 |
177 | intracellular lipid transport (GO:0032365) | 2.16488905 |
178 | carnitine transport (GO:0015879) | 2.13443994 |
179 | amino-acid betaine transport (GO:0015838) | 2.13443994 |
180 | regulation of gamma-delta T cell activation (GO:0046643) | 2.12387350 |
181 | ethanol oxidation (GO:0006069) | 2.11636750 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.49404579 |
2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.08990022 |
3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.00359286 |
4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.88876244 |
5 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.82757739 |
6 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 3.81406993 |
7 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.51331160 |
8 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.49272761 |
9 | * IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.99269193 |
10 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.85013501 |
11 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.83047137 |
12 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.81502307 |
13 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.75499519 |
14 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.64121232 |
15 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.56013498 |
16 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.48247201 |
17 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.46554304 |
18 | * ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.30394837 |
19 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.27400874 |
20 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.94253108 |
21 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.91365130 |
22 | * VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.78852913 |
23 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.78745499 |
24 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.77209252 |
25 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.76885521 |
26 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.75508694 |
27 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.75310865 |
28 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.70982264 |
29 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.69631838 |
30 | GATA1_22025678_ChIP-Seq_K562_Human | 1.69536832 |
31 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.67719735 |
32 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.62276626 |
33 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.61741158 |
34 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.61398345 |
35 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.59166909 |
36 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.56924899 |
37 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.54665594 |
38 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.52757922 |
39 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.51458443 |
40 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.51199003 |
41 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.49816909 |
42 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.48246118 |
43 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.44617123 |
44 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.44450606 |
45 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.44405700 |
46 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.41419641 |
47 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.41419641 |
48 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 1.40918850 |
49 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.39523502 |
50 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.39100615 |
51 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.38164802 |
52 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.35423337 |
53 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.32451242 |
54 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.27860463 |
55 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.26887772 |
56 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.26216271 |
57 | * SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.24636589 |
58 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.24564567 |
59 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.23054969 |
60 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.21453950 |
61 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.19953698 |
62 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.18937391 |
63 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.18937391 |
64 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.17366985 |
65 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.15957778 |
66 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.14874462 |
67 | GATA1_19941826_ChIP-Seq_K562_Human | 1.14745158 |
68 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.14254160 |
69 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.13364119 |
70 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.11865404 |
71 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.11209722 |
72 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.10319018 |
73 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.10070932 |
74 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.09005909 |
75 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.08995904 |
76 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.08353655 |
77 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.08103651 |
78 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.08084788 |
79 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.07307747 |
80 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.06860164 |
81 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.06320113 |
82 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.05291896 |
83 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.02958772 |
84 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.02422264 |
85 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.01781896 |
86 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.99504173 |
87 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.99354471 |
88 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.98133624 |
89 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.98133624 |
90 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.98133624 |
91 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.97447682 |
92 | GATA2_19941826_ChIP-Seq_K562_Human | 0.97151921 |
93 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.96853780 |
94 | * GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.96738176 |
95 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.94276397 |
96 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.94220589 |
97 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.93824116 |
98 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.91991920 |
99 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.91092853 |
100 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.90927745 |
101 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.90216006 |
102 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.90071009 |
103 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.89990893 |
104 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 0.89986147 |
105 | TP53_16413492_ChIP-PET_HCT116_Human | 0.89739126 |
106 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.89307256 |
107 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.88989133 |
108 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.88344805 |
109 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.88065051 |
110 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.87676348 |
111 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.87536587 |
112 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.86388297 |
113 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.86345286 |
114 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.86167676 |
115 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.85862985 |
116 | CJUN_26792858_Chip-Seq_BT549_Human | 0.85664442 |
117 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.85596134 |
118 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.84388044 |
119 | RXR_22108803_ChIP-Seq_LS180_Human | 0.84163900 |
120 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.83125205 |
121 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.83030212 |
122 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.82658148 |
123 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.81410113 |
124 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.80313019 |
125 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.78598481 |
126 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.78455852 |
127 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.77339442 |
128 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.77159924 |
129 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.76465147 |
130 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.76355740 |
131 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.76350716 |
132 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.76350716 |
133 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.75394309 |
134 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.73639947 |
135 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.73472393 |
136 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.73368805 |
137 | NANOG_18692474_ChIP-Seq_MESCs_Mouse | 0.72347850 |
138 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.72062168 |
139 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.71761726 |
140 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.71113762 |
141 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.70715675 |
142 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.69405343 |
143 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.69262162 |
144 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.68901778 |
145 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.68646755 |
146 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.68385617 |
147 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.68029797 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0009840_abnormal_foam_cell | 4.09170294 |
2 | MP0005451_abnormal_body_composition | 3.62411907 |
3 | MP0002139_abnormal_hepatobiliary_system | 3.33270876 |
4 | MP0003806_abnormal_nucleotide_metabolis | 3.20828854 |
5 | MP0005360_urolithiasis | 3.06276999 |
6 | MP0005085_abnormal_gallbladder_physiolo | 2.99352527 |
7 | MP0008260_abnormal_autophagy | 2.69002660 |
8 | MP0000920_abnormal_myelination | 2.49428142 |
9 | MP0003183_abnormal_peptide_metabolism | 2.47989638 |
10 | MP0003950_abnormal_plasma_membrane | 2.46908737 |
11 | MP0006082_CNS_inflammation | 2.42950055 |
12 | MP0005365_abnormal_bile_salt | 2.41101631 |
13 | MP0005058_abnormal_lysosome_morphology | 2.37162060 |
14 | MP0010678_abnormal_skin_adnexa | 2.29959229 |
15 | MP0000383_abnormal_hair_follicle | 2.29324757 |
16 | MP0003283_abnormal_digestive_organ | 2.27828940 |
17 | MP0003690_abnormal_glial_cell | 2.24420399 |
18 | MP0008875_abnormal_xenobiotic_pharmacok | 2.22097665 |
19 | MP0008004_abnormal_stomach_pH | 2.17539013 |
20 | MP0009785_altered_susceptibility_to | 2.06918796 |
21 | MP0003300_gastrointestinal_ulcer | 1.97046402 |
22 | MP0003195_calcinosis | 1.93192617 |
23 | MP0003186_abnormal_redox_activity | 1.92898607 |
24 | MP0001835_abnormal_antigen_presentation | 1.92393228 |
25 | MP0002148_abnormal_hypersensitivity_rea | 1.87571235 |
26 | MP0005083_abnormal_biliary_tract | 1.87161792 |
27 | MP0005332_abnormal_amino_acid | 1.85828235 |
28 | MP0004264_abnormal_extraembryonic_tissu | 1.82860923 |
29 | MP0003172_abnormal_lysosome_physiology | 1.82697840 |
30 | MP0003718_maternal_effect | 1.82664135 |
31 | MP0002254_reproductive_system_inflammat | 1.81685270 |
32 | MP0003191_abnormal_cellular_cholesterol | 1.81503243 |
33 | MP0003453_abnormal_keratinocyte_physiol | 1.81270307 |
34 | MP0005408_hypopigmentation | 1.79691622 |
35 | MP0009764_decreased_sensitivity_to | 1.73792827 |
36 | MP0004381_abnormal_hair_follicle | 1.73236362 |
37 | MP0002419_abnormal_innate_immunity | 1.64269858 |
38 | MP0003656_abnormal_erythrocyte_physiolo | 1.58718137 |
39 | MP0003136_yellow_coat_color | 1.56017095 |
40 | MP0005025_abnormal_response_to | 1.52344988 |
41 | MP0002796_impaired_skin_barrier | 1.48090567 |
42 | MP0010329_abnormal_lipoprotein_level | 1.46239306 |
43 | MP0000579_abnormal_nail_morphology | 1.44324813 |
44 | MP0010155_abnormal_intestine_physiology | 1.42336455 |
45 | MP0000604_amyloidosis | 1.41639079 |
46 | MP0000647_abnormal_sebaceous_gland | 1.40955184 |
47 | MP0005670_abnormal_white_adipose | 1.38391816 |
48 | MP0005671_abnormal_response_to | 1.38201418 |
49 | MP0004947_skin_inflammation | 1.34652886 |
50 | MP0001666_abnormal_nutrient_absorption | 1.33914391 |
51 | MP0005275_abnormal_skin_tensile | 1.33210145 |
52 | MP0004019_abnormal_vitamin_homeostasis | 1.32603094 |
53 | MP0003436_decreased_susceptibility_to | 1.32484407 |
54 | MP0003724_increased_susceptibility_to | 1.31962468 |
55 | MP0005171_absent_coat_pigmentation | 1.31550439 |
56 | MP0002118_abnormal_lipid_homeostasis | 1.31053657 |
57 | MP0001661_extended_life_span | 1.28195795 |
58 | MP0003252_abnormal_bile_duct | 1.22480844 |
59 | MP0009697_abnormal_copulation | 1.22110508 |
60 | MP0008469_abnormal_protein_level | 1.20626540 |
61 | MP0001346_abnormal_lacrimal_gland | 1.20187990 |
62 | MP0005000_abnormal_immune_tolerance | 1.19790159 |
63 | MP0000609_abnormal_liver_physiology | 1.19468883 |
64 | MP0003868_abnormal_feces_composition | 1.19066306 |
65 | MP0002166_altered_tumor_susceptibility | 1.17963224 |
66 | MP0000685_abnormal_immune_system | 1.12965544 |
67 | MP0009643_abnormal_urine_homeostasis | 1.09633017 |
68 | MP0002098_abnormal_vibrissa_morphology | 1.07950693 |
69 | MP0005409_darkened_coat_color | 1.07882701 |
70 | MP0005319_abnormal_enzyme/_coenzyme | 1.07456464 |
71 | MP0002998_abnormal_bone_remodeling | 1.07055470 |
72 | MP0001756_abnormal_urination | 1.05839312 |
73 | MP0000465_gastrointestinal_hemorrhage | 1.05565856 |
74 | MP0003646_muscle_fatigue | 1.04650038 |
75 | MP0002723_abnormal_immune_serum | 1.03292550 |
76 | MP0003045_fibrosis | 1.02625724 |
77 | MP0003448_altered_tumor_morphology | 1.01361442 |
78 | MP0003879_abnormal_hair_cell | 0.99442510 |
79 | MP0001790_abnormal_immune_system | 0.98398002 |
80 | MP0005387_immune_system_phenotype | 0.98398002 |
81 | MP0004510_myositis | 0.98376184 |
82 | MP0009115_abnormal_fat_cell | 0.98325144 |
83 | MP0005167_abnormal_blood-brain_barrier | 0.98264304 |
84 | MP0003075_altered_response_to | 0.97880994 |
85 | MP0002452_abnormal_antigen_presenting | 0.96260898 |
86 | MP0002971_abnormal_brown_adipose | 0.95510309 |
87 | MP0001845_abnormal_inflammatory_respons | 0.95303288 |
88 | MP0005395_other_phenotype | 0.94993354 |
89 | MP0003091_abnormal_cell_migration | 0.94667475 |
90 | MP0005310_abnormal_salivary_gland | 0.93214583 |
91 | MP0005023_abnormal_wound_healing | 0.90219122 |
92 | MP0005464_abnormal_platelet_physiology | 0.89965943 |
93 | MP0010352_gastrointestinal_tract_polyps | 0.89746553 |
94 | MP0000371_diluted_coat_color | 0.89721166 |
95 | MP0010386_abnormal_urinary_bladder | 0.89612687 |
96 | MP0009763_increased_sensitivity_to | 0.89600576 |
97 | MP0002295_abnormal_pulmonary_circulatio | 0.88262157 |
98 | MP0005666_abnormal_adipose_tissue | 0.88101358 |
99 | MP0001873_stomach_inflammation | 0.87757010 |
100 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.87158955 |
101 | MP0003329_amyloid_beta_deposits | 0.87024814 |
102 | MP0002136_abnormal_kidney_physiology | 0.86421508 |
103 | MP0005164_abnormal_response_to | 0.86302831 |
104 | MP0003828_pulmonary_edema | 0.86292105 |
105 | MP0002138_abnormal_hepatobiliary_system | 0.86130737 |
106 | MP0001819_abnormal_immune_cell | 0.85816933 |
107 | MP0002420_abnormal_adaptive_immunity | 0.85507853 |
108 | MP0001216_abnormal_epidermal_layer | 0.85084291 |
109 | MP0001800_abnormal_humoral_immune | 0.84303616 |
110 | MP0000377_abnormal_hair_follicle | 0.83555201 |
111 | MP0010234_abnormal_vibrissa_follicle | 0.83197879 |
112 | MP0002822_catalepsy | 0.82198545 |
113 | MP0004885_abnormal_endolymph | 0.81083448 |
114 | MP0002009_preneoplasia | 0.77776283 |
115 | MP0004185_abnormal_adipocyte_glucose | 0.77698923 |
116 | MP0006138_congestive_heart_failure | 0.77647103 |
117 | MP0000372_irregular_coat_pigmentation | 0.77579554 |
118 | MP0005257_abnormal_intraocular_pressure | 0.76599798 |
119 | MP0004883_abnormal_blood_vessel | 0.76298605 |
120 | MP0000516_abnormal_urinary_system | 0.76269909 |
121 | MP0005367_renal/urinary_system_phenotyp | 0.76269909 |
122 | MP0000343_altered_response_to | 0.76146349 |
123 | MP0005647_abnormal_sex_gland | 0.75510684 |
124 | MP0005166_decreased_susceptibility_to | 0.73739036 |
125 | MP0001533_abnormal_skeleton_physiology | 0.73618174 |
126 | MP0004782_abnormal_surfactant_physiolog | 0.73558433 |
127 | MP0006054_spinal_hemorrhage | 0.73495088 |
128 | MP0001881_abnormal_mammary_gland | 0.71683027 |
129 | MP0009765_abnormal_xenobiotic_induced | 0.69981420 |
130 | MP0003566_abnormal_cell_adhesion | 0.69956819 |
131 | MP0000627_abnormal_mammary_gland | 0.69061002 |
132 | MP0002405_respiratory_system_inflammati | 0.66968724 |
133 | MP0009333_abnormal_splenocyte_physiolog | 0.66615549 |
134 | MP0003303_peritoneal_inflammation | 0.65768915 |
135 | MP0001853_heart_inflammation | 0.65500562 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.28187858 |
2 | Intrahepatic cholestasis (HP:0001406) | 4.20711850 |
3 | Parakeratosis (HP:0001036) | 4.04990101 |
4 | Malnutrition (HP:0004395) | 3.81734985 |
5 | Xanthomatosis (HP:0000991) | 3.80301664 |
6 | Asymmetric septal hypertrophy (HP:0001670) | 3.67755775 |
7 | Hyperlipoproteinemia (HP:0010980) | 3.60044433 |
8 | Axonal loss (HP:0003447) | 3.44977791 |
9 | Abnormality of macrophages (HP:0004311) | 3.42625583 |
10 | Recurrent bacterial skin infections (HP:0005406) | 3.34712693 |
11 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.34174132 |
12 | Deep venous thrombosis (HP:0002625) | 3.31937590 |
13 | Muscle fiber splitting (HP:0003555) | 3.25668518 |
14 | Abnormality of glycine metabolism (HP:0010895) | 3.18184203 |
15 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.18184203 |
16 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.12038505 |
17 | Hyperglycinemia (HP:0002154) | 3.11262079 |
18 | Dysostosis multiplex (HP:0000943) | 3.11090445 |
19 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 3.10394092 |
20 | Neurofibrillary tangles (HP:0002185) | 3.06469284 |
21 | Hyperglycinuria (HP:0003108) | 3.06024116 |
22 | Vacuolated lymphocytes (HP:0001922) | 2.94140616 |
23 | Gastrointestinal stroma tumor (HP:0100723) | 2.93274380 |
24 | Myocardial infarction (HP:0001658) | 2.91324966 |
25 | Prolonged partial thromboplastin time (HP:0003645) | 2.91242018 |
26 | Prolonged neonatal jaundice (HP:0006579) | 2.85654163 |
27 | Mucopolysacchariduria (HP:0008155) | 2.84971226 |
28 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.84971226 |
29 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.84319682 |
30 | Hemorrhage of the eye (HP:0011885) | 2.79808827 |
31 | Hepatosplenomegaly (HP:0001433) | 2.79124770 |
32 | Recurrent abscess formation (HP:0002722) | 2.77929729 |
33 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.73127178 |
34 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.73127178 |
35 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.73127178 |
36 | Pustule (HP:0200039) | 2.71656803 |
37 | Eczematoid dermatitis (HP:0000976) | 2.68634187 |
38 | Spastic paraparesis (HP:0002313) | 2.66538244 |
39 | Osteolytic defects of the hand bones (HP:0009699) | 2.65448566 |
40 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.65448566 |
41 | Increased IgE level (HP:0003212) | 2.62375216 |
42 | Exercise-induced myalgia (HP:0003738) | 2.62123524 |
43 | Paraparesis (HP:0002385) | 2.59304318 |
44 | Cerebral hemorrhage (HP:0001342) | 2.57993867 |
45 | Complement deficiency (HP:0004431) | 2.56760525 |
46 | Hypobetalipoproteinemia (HP:0003563) | 2.55187235 |
47 | Systemic lupus erythematosus (HP:0002725) | 2.54915363 |
48 | Fat malabsorption (HP:0002630) | 2.53390717 |
49 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.51411666 |
50 | Thick nail (HP:0001805) | 2.49573695 |
51 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.47822509 |
52 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.47430764 |
53 | Vascular calcification (HP:0004934) | 2.40225030 |
54 | Erythroderma (HP:0001019) | 2.39376481 |
55 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.37707589 |
56 | Joint hemorrhage (HP:0005261) | 2.37701594 |
57 | Cerebral hypomyelination (HP:0006808) | 2.37328446 |
58 | Hyporeflexia of lower limbs (HP:0002600) | 2.36835517 |
59 | Spastic tetraparesis (HP:0001285) | 2.36564116 |
60 | Colitis (HP:0002583) | 2.36561396 |
61 | Steatorrhea (HP:0002570) | 2.36477072 |
62 | Abnormality of serum amino acid levels (HP:0003112) | 2.35814709 |
63 | Glomerulonephritis (HP:0000099) | 2.34738530 |
64 | Abnormality of methionine metabolism (HP:0010901) | 2.34215278 |
65 | Epidermoid cyst (HP:0200040) | 2.32451372 |
66 | Hydroxyprolinuria (HP:0003080) | 2.24789365 |
67 | Abnormality of proline metabolism (HP:0010907) | 2.24789365 |
68 | Right ventricular cardiomyopathy (HP:0011663) | 2.24304454 |
69 | Hyperammonemia (HP:0001987) | 2.24280776 |
70 | Alopecia of scalp (HP:0002293) | 2.24164353 |
71 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.22818472 |
72 | Hypolipoproteinemia (HP:0010981) | 2.21868864 |
73 | Loss of speech (HP:0002371) | 2.20873767 |
74 | Gingival bleeding (HP:0000225) | 2.20154661 |
75 | Emphysema (HP:0002097) | 2.19008327 |
76 | Peripheral demyelination (HP:0011096) | 2.18312445 |
77 | Hypoalphalipoproteinemia (HP:0003233) | 2.18219893 |
78 | Stenosis of the external auditory canal (HP:0000402) | 2.17469645 |
79 | Recurrent skin infections (HP:0001581) | 2.17022818 |
80 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.14318693 |
81 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.14318693 |
82 | Conjugated hyperbilirubinemia (HP:0002908) | 2.13379368 |
83 | Onion bulb formation (HP:0003383) | 2.11767454 |
84 | Purpura (HP:0000979) | 2.10070763 |
85 | Polycythemia (HP:0001901) | 2.09315763 |
86 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.09097582 |
87 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.09097582 |
88 | Abnormality of glycolipid metabolism (HP:0010969) | 2.09097582 |
89 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.08552727 |
90 | Osteomyelitis (HP:0002754) | 2.08550271 |
91 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.08472771 |
92 | Recurrent pneumonia (HP:0006532) | 2.07118525 |
93 | Vasculitis (HP:0002633) | 2.04937048 |
94 | Amyloidosis (HP:0011034) | 2.04710576 |
95 | Esophageal varix (HP:0002040) | 2.04633664 |
96 | Nausea (HP:0002018) | 2.04465400 |
97 | Neonatal hypoglycemia (HP:0001998) | 2.02705152 |
98 | Ureteral duplication (HP:0000073) | 2.02663456 |
99 | Restrictive lung disease (HP:0002091) | 2.02360341 |
100 | Recurrent sinusitis (HP:0011108) | 2.02295180 |
101 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.02177890 |
102 | Cardiovascular calcification (HP:0011915) | 2.01754985 |
103 | Hyperkalemia (HP:0002153) | 1.99254600 |
104 | Autoimmune thrombocytopenia (HP:0001973) | 1.98959854 |
105 | Gastrointestinal infarctions (HP:0005244) | 1.98162756 |
106 | Joint swelling (HP:0001386) | 1.96275217 |
107 | Nephritis (HP:0000123) | 1.95921602 |
108 | Chronic diarrhea (HP:0002028) | 1.95760607 |
109 | Abnormality of complement system (HP:0005339) | 1.94870971 |
110 | Aortic aneurysm (HP:0004942) | 1.93446628 |
111 | Increased cerebral lipofuscin (HP:0011813) | 1.92869435 |
112 | Abnormality of secondary sexual hair (HP:0009888) | 1.92558329 |
113 | Abnormality of the axillary hair (HP:0100134) | 1.92558329 |
114 | Autoamputation (HP:0001218) | 1.90947991 |
115 | Abnormality of the umbilical cord (HP:0010881) | 1.90678526 |
116 | Spontaneous abortion (HP:0005268) | 1.90627635 |
117 | Gastrointestinal inflammation (HP:0004386) | 1.90357539 |
118 | Inflammation of the large intestine (HP:0002037) | 1.90313272 |
119 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.89972987 |
120 | Flat acetabular roof (HP:0003180) | 1.89935718 |
121 | Gingivitis (HP:0000230) | 1.88757511 |
122 | Orchitis (HP:0100796) | 1.85545688 |
123 | Abnormality of the common coagulation pathway (HP:0010990) | 1.84714038 |
124 | Increased serum ferritin (HP:0003281) | 1.84381022 |
125 | Gangrene (HP:0100758) | 1.83741627 |
126 | Meningitis (HP:0001287) | 1.83413598 |
127 | Interstitial pulmonary disease (HP:0006530) | 1.82438230 |
128 | Lip pit (HP:0100267) | 1.81822830 |
129 | Mediastinal lymphadenopathy (HP:0100721) | 1.81289366 |
130 | Stomatitis (HP:0010280) | 1.81124936 |
131 | Cerebral inclusion bodies (HP:0100314) | 1.79298226 |
132 | Corneal erosion (HP:0200020) | 1.78125978 |
133 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.77923455 |
134 | Abnormality of iron homeostasis (HP:0011031) | 1.77868350 |
135 | Hypercholesterolemia (HP:0003124) | 1.76637695 |
136 | Retrobulbar optic neuritis (HP:0100654) | 1.75988717 |
137 | Optic neuritis (HP:0100653) | 1.75988717 |
138 | Focal segmental glomerulosclerosis (HP:0000097) | 1.75818963 |
139 | Slow saccadic eye movements (HP:0000514) | 1.75363461 |
140 | Spondylolisthesis (HP:0003302) | 1.75138213 |
141 | Tetraparesis (HP:0002273) | 1.74960934 |
142 | Cerebral aneurysm (HP:0004944) | 1.74570013 |
143 | Irritability (HP:0000737) | 1.74069917 |
144 | Abnormality of the periventricular white matter (HP:0002518) | 1.74041370 |
145 | Spontaneous hematomas (HP:0007420) | 1.70518481 |
146 | Gonadotropin excess (HP:0000837) | 1.69152288 |
147 | Agammaglobulinemia (HP:0004432) | 1.68922848 |
148 | Metaphyseal irregularity (HP:0003025) | 1.68625988 |
149 | Hypophosphatemic rickets (HP:0004912) | 1.68537392 |
150 | Ovoid vertebral bodies (HP:0003300) | 1.67248310 |
151 | Hyperactive renin-angiotensin system (HP:0000841) | 1.66068969 |
152 | Recurrent bronchitis (HP:0002837) | 1.65558253 |
153 | Rhabdomyolysis (HP:0003201) | 1.62946806 |
154 | Pulmonary infiltrates (HP:0002113) | 1.62798667 |
155 | Thin bony cortex (HP:0002753) | 1.61933205 |
156 | Cellulitis (HP:0100658) | 1.61660819 |
157 | Pulmonary embolism (HP:0002204) | 1.61469274 |
Rank | Gene Set | Z-score |
---|---|---|
1 | PBK | 4.82243159 |
2 | STK39 | 3.57119589 |
3 | ERN1 | 3.16727236 |
4 | EPHB1 | 3.12358390 |
5 | ACVR1B | 2.95100893 |
6 | MST4 | 2.88436149 |
7 | MAP3K14 | 2.85162370 |
8 | MET | 2.73324514 |
9 | OXSR1 | 2.54592527 |
10 | DDR2 | 2.17612086 |
11 | RIPK1 | 2.07636144 |
12 | EPHA2 | 2.05485884 |
13 | BLK | 2.01336677 |
14 | PKN1 | 1.98166469 |
15 | PINK1 | 1.92299021 |
16 | MAP3K13 | 1.90556990 |
17 | MST1R | 1.88552515 |
18 | EEF2K | 1.87793521 |
19 | TBK1 | 1.83505193 |
20 | IRAK3 | 1.82938757 |
21 | ERBB4 | 1.73222661 |
22 | IKBKB | 1.67371745 |
23 | BCKDK | 1.65007025 |
24 | TYK2 | 1.63756777 |
25 | CDC42BPA | 1.63008148 |
26 | FGFR3 | 1.60949795 |
27 | FGFR2 | 1.54940293 |
28 | MAP4K1 | 1.54785556 |
29 | AKT3 | 1.51797474 |
30 | FGR | 1.51495802 |
31 | CDK12 | 1.49833840 |
32 | TRIB3 | 1.48409500 |
33 | BCR | 1.48123259 |
34 | ARAF | 1.44754239 |
35 | TNK2 | 1.43984052 |
36 | RIPK4 | 1.34713739 |
37 | MAPKAPK3 | 1.33722025 |
38 | NTRK1 | 1.31748499 |
39 | IKBKE | 1.30220975 |
40 | STK3 | 1.28721281 |
41 | MATK | 1.24840242 |
42 | TRPM7 | 1.24778340 |
43 | TGFBR2 | 1.18592871 |
44 | PRPF4B | 1.18292685 |
45 | NME2 | 1.16571658 |
46 | NLK | 1.15088758 |
47 | GRK7 | 1.14425597 |
48 | PNCK | 1.11192123 |
49 | MAP3K2 | 1.09641456 |
50 | STK4 | 1.06823161 |
51 | LATS1 | 1.04594880 |
52 | CSNK1G1 | 1.02268916 |
53 | CSNK1G3 | 1.01984643 |
54 | CAMK1D | 1.01911853 |
55 | MAPKAPK5 | 1.00831051 |
56 | PLK4 | 0.97088871 |
57 | MAP3K7 | 0.96867041 |
58 | MARK2 | 0.95170635 |
59 | MAP3K10 | 0.95070441 |
60 | ABL2 | 0.94982213 |
61 | MAPK12 | 0.94871458 |
62 | FER | 0.94193182 |
63 | MAP2K2 | 0.93590580 |
64 | CSNK1A1L | 0.92572280 |
65 | SIK1 | 0.91187202 |
66 | FGFR4 | 0.90330040 |
67 | DMPK | 0.88196524 |
68 | STK10 | 0.88052294 |
69 | SGK2 | 0.87853974 |
70 | NEK9 | 0.87270978 |
71 | FRK | 0.87023430 |
72 | MAPK11 | 0.87021186 |
73 | EPHA3 | 0.85499183 |
74 | KIT | 0.84706776 |
75 | PDK1 | 0.84357191 |
76 | OBSCN | 0.83450562 |
77 | BMPR1B | 0.83231935 |
78 | NUAK1 | 0.82782383 |
79 | PDK2 | 0.81459452 |
80 | MAP3K1 | 0.81142034 |
81 | CAMK2G | 0.80461744 |
82 | SGK3 | 0.79509416 |
83 | PDPK1 | 0.77954508 |
84 | CSK | 0.76445545 |
85 | EIF2AK3 | 0.75611065 |
86 | JAK1 | 0.74145099 |
87 | JAK3 | 0.72593106 |
88 | TNIK | 0.71328479 |
89 | SYK | 0.71205101 |
90 | STK24 | 0.70971301 |
91 | CHUK | 0.70819211 |
92 | BMX | 0.69395065 |
93 | TAOK3 | 0.69314769 |
94 | CAMK1G | 0.68008882 |
95 | LYN | 0.67340033 |
96 | PDGFRA | 0.65891719 |
97 | MAP2K3 | 0.65874047 |
98 | TAOK1 | 0.63476586 |
99 | PRKD2 | 0.62691607 |
100 | IRAK4 | 0.62663276 |
101 | KSR2 | 0.60327443 |
102 | WNK4 | 0.60274396 |
103 | CSF1R | 0.60211166 |
104 | ZAP70 | 0.60031086 |
105 | CAMK2D | 0.59720526 |
106 | NEK6 | 0.58807580 |
107 | BUB1 | 0.58638907 |
108 | CSNK1G2 | 0.58586105 |
109 | PRKG2 | 0.56986640 |
110 | GSK3A | 0.56962245 |
111 | WNK1 | 0.56049660 |
112 | TTN | 0.55701466 |
113 | ABL1 | 0.55658785 |
114 | PIK3CA | 0.55476975 |
115 | BRAF | 0.53069474 |
116 | BTK | 0.53022460 |
117 | PAK3 | 0.52644591 |
118 | ICK | 0.52585901 |
119 | PIK3CG | 0.50955884 |
120 | SGK494 | 0.50739796 |
121 | SGK223 | 0.50739796 |
122 | PKN2 | 0.50688416 |
123 | CDK19 | 0.49760670 |
124 | PRKCQ | 0.49385713 |
125 | PIM2 | 0.48795033 |
126 | STK38L | 0.48113314 |
127 | JAK2 | 0.47533748 |
128 | LRRK2 | 0.47220313 |
129 | PRKAA2 | 0.46724719 |
130 | MARK3 | 0.46311732 |
131 | BMPR2 | 0.46029698 |
132 | TGFBR1 | 0.46003507 |
133 | MELK | 0.45992787 |
134 | CDK9 | 0.45735282 |
135 | HCK | 0.44956429 |
136 | PDGFRB | 0.44956166 |
137 | RET | 0.44126716 |
138 | WEE1 | 0.43581404 |
139 | ERBB2 | 0.43417281 |
140 | MUSK | 0.42570984 |
141 | PAK2 | 0.42477909 |
142 | RPS6KA5 | 0.42060506 |
143 | RPS6KA2 | 0.41137053 |
144 | MAPK7 | 0.40763026 |
145 | CAMK2B | 0.40680879 |
146 | TYRO3 | 0.40533433 |
147 | MOS | 0.40368803 |
148 | EGFR | 0.39238189 |
149 | PRKCE | 0.38165454 |
150 | MAP3K3 | 0.37099745 |
151 | IRAK1 | 0.35652027 |
152 | PRKD1 | 0.35217398 |
153 | EIF2AK2 | 0.35130241 |
154 | DAPK3 | 0.34846968 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 3.47558407 |
2 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.80228214 |
3 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.75687637 |
4 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.56233801 |
5 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.49891542 |
6 | Histidine metabolism_Homo sapiens_hsa00340 | 2.48065714 |
7 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.41784944 |
8 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.28274727 |
9 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.24508297 |
10 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 2.04013839 |
11 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.90226118 |
12 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.85699827 |
13 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.85488709 |
14 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.81173250 |
15 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.80500595 |
16 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.71999296 |
17 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.71937152 |
18 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.63700171 |
19 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.62582051 |
20 | Peroxisome_Homo sapiens_hsa04146 | 1.59230641 |
21 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.54032904 |
22 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.53536887 |
23 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.51247440 |
24 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.50727498 |
25 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.45476848 |
26 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.43017480 |
27 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.42393162 |
28 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.41075518 |
29 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.39694172 |
30 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.35972731 |
31 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.35360322 |
32 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.34626407 |
33 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.34404862 |
34 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.33239921 |
35 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.32571620 |
36 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.30809400 |
37 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.30041594 |
38 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.26358268 |
39 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.25718313 |
40 | Lysosome_Homo sapiens_hsa04142 | 1.25197104 |
41 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.23857619 |
42 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.22299924 |
43 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.21600321 |
44 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.21440472 |
45 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.20888641 |
46 | Allograft rejection_Homo sapiens_hsa05330 | 1.19348120 |
47 | Retinol metabolism_Homo sapiens_hsa00830 | 1.17044343 |
48 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.13541890 |
49 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.12515189 |
50 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.11274247 |
51 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.07907327 |
52 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.07476429 |
53 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.06495039 |
54 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.03042427 |
55 | Malaria_Homo sapiens_hsa05144 | 1.01268594 |
56 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.99522465 |
57 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.96923053 |
58 | Insulin resistance_Homo sapiens_hsa04931 | 0.95174312 |
59 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.94910476 |
60 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.92853105 |
61 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.92479847 |
62 | Legionellosis_Homo sapiens_hsa05134 | 0.91616073 |
63 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.87238097 |
64 | Leishmaniasis_Homo sapiens_hsa05140 | 0.86754671 |
65 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.86664470 |
66 | Pertussis_Homo sapiens_hsa05133 | 0.86266306 |
67 | Viral myocarditis_Homo sapiens_hsa05416 | 0.86079909 |
68 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.85786922 |
69 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.84261494 |
70 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.84254442 |
71 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.81712444 |
72 | Mineral absorption_Homo sapiens_hsa04978 | 0.79475424 |
73 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.79138021 |
74 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.73151921 |
75 | Prion diseases_Homo sapiens_hsa05020 | 0.71701340 |
76 | Proteasome_Homo sapiens_hsa03050 | 0.71126760 |
77 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.70241784 |
78 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.69404085 |
79 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.69304852 |
80 | Galactose metabolism_Homo sapiens_hsa00052 | 0.68687310 |
81 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.68411072 |
82 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.67183639 |
83 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.66897392 |
84 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.66849999 |
85 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.66709013 |
86 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.65898998 |
87 | ABC transporters_Homo sapiens_hsa02010 | 0.65827187 |
88 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.65135142 |
89 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.64626564 |
90 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.63836119 |
91 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.63416053 |
92 | Phagosome_Homo sapiens_hsa04145 | 0.63114656 |
93 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.62507506 |
94 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.59435383 |
95 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.58697161 |
96 | Bile secretion_Homo sapiens_hsa04976 | 0.58293388 |
97 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.57289058 |
98 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.56615346 |
99 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.56507645 |
100 | Circadian rhythm_Homo sapiens_hsa04710 | 0.56339600 |
101 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.55772344 |
102 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.55457954 |
103 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.55110407 |
104 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.54285960 |
105 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.53272806 |
106 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.52770758 |
107 | Tuberculosis_Homo sapiens_hsa05152 | 0.52212529 |
108 | Salmonella infection_Homo sapiens_hsa05132 | 0.51732363 |
109 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.50129185 |
110 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.49373700 |
111 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.48236249 |
112 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.46516157 |
113 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.46266151 |
114 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.45997262 |
115 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.45108962 |
116 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.44557372 |
117 | Hepatitis C_Homo sapiens_hsa05160 | 0.44336384 |
118 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.43563527 |
119 | Amoebiasis_Homo sapiens_hsa05146 | 0.43496818 |
120 | Asthma_Homo sapiens_hsa05310 | 0.42075014 |
121 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.41430854 |
122 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.41012654 |
123 | Metabolic pathways_Homo sapiens_hsa01100 | 0.40492021 |
124 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.40080527 |
125 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.39751413 |
126 | Platelet activation_Homo sapiens_hsa04611 | 0.39722102 |
127 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.39325401 |
128 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.38233204 |
129 | Other glycan degradation_Homo sapiens_hsa00511 | 0.37349563 |
130 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.36360393 |
131 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.36201035 |
132 | Influenza A_Homo sapiens_hsa05164 | 0.35818686 |
133 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.34124269 |
134 | Carbon metabolism_Homo sapiens_hsa01200 | 0.33852536 |
135 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.32255944 |